Coya Therapeutics, Inc. (COYA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 8.50 |
| Open | 8.50 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 8.34 - 8.79 |
| 52-week range | 3.21 - 10.69 |
| Volume | |
| Avg. volume | 89,858 |
| Market cap | 127.617M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.79 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.50 |
Simply Wall St.Coya Therapeutics, Inc.'s (NASDAQ:COYA) largest shareholders are retail investors with 60% ownership, insiders own 16%
Key Insights The considerable ownership by retail investors in Coya Therapeutics indicates that they collectively have...
- GuruFocus.com
Coya Therapeutics Reports First Quarter 2024 Financial Results
Performance Misses Analyst Estimates Amidst Expanding Clinical Pipeline
- Business Wire
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
HOUSTON, May 09, 2024--Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a corporate update and announces its financial results for the quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.